Table 2.
Cycle characteristics and treatment outcomes of the study group
| Control group n = 40 | Total patient Group n = 69 | p value | |
|---|---|---|---|
| Total dose of gonadotropin used (IU) | 1793.7 ± 600.7 | 2046.7 ± 833.4 | p > 0.05 |
| E2 levels on the day of HCG administration (pg/mL) | 1727.9 ± 1115.3 | 1987.8 ± 1021.7 | p > 0.05 |
| Endometrium thickness (mm) | 9.4 ± 2.4 | 9.7 ± 2.6 | p > 0.05 |
| No of oocyte retrieved | 9.3 ± 4.3 | 8.7 ± 4.1 | p > 0.05 |
| No of mature oocyte | 6.8 ± 3.3 | 6.4 ± 3.3 | p > 0.05 |
| Fertilization rate (%) | 79.4 ± 17.4 | 82.7 ± 19.6 | p > 0.05 |
| No of embryo transfered | 1.3 ± 0.6 | 1.2 ± 0.4 | p > 0.05 |
| Clinical pregnancy rate (%) | 50 (20/40) | 36.2 (25/69) | p > 0.05 |
Data were expressed as mean ± standard error